radium has been researched along with Adverse Drug Event in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (14.29) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (14.29) | 29.6817 |
2010's | 4 (57.14) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Connor, MJ; Hattangadi-Gluth, JA; Huynh-Le, MP; Shults, RC | 1 |
Carles, J; Gillessen, S; Heidenreich, A; Heinrich, D; Keizman, D; Miller, K; Nilsson, S; O'Sullivan, JM; Reeves, J; Saad, F; Seger, M; Wirth, M | 1 |
Iijima, M; Iwamoto, H; Izumi, K; Kadomoto, S; Kadono, Y; Kawaguchi, S; Makino, T; Matsuo, S; Mizokami, A; Nakashima, K; Nohara, T; Shigehara, K; Yaegashi, H | 1 |
Barkin, J; Mak, V | 1 |
Au, WY; Raisz, LG | 1 |
Stephenson, J; ThuyTrinh, LT; Vajda, J | 1 |
1 review(s) available for radium and Adverse Drug Event
Article | Year |
---|---|
Drugs toxic to bone.
Topics: Adrenal Cortex Hormones; Antacids; Antibiotics, Antineoplastic; Anticoagulants; Anticonvulsants; Bone and Bones; Bone Diseases; Cadmium; Cathartics; Chronic Disease; Dactinomycin; Diuretics; Drug-Related Side Effects and Adverse Reactions; Fluorides; Humans; Hyperparathyroidism, Secondary; Iron; Lead; Methotrexate; Plicamycin; Radium; Tetracycline; Vitamin A; Vitamin D | 1972 |
1 trial(s) available for radium and Adverse Drug Event
Article | Year |
---|---|
Radium-223 in asymptomatic patients with castration-resistant prostate cancer and bone metastases treated in an international early access program.
Topics: Aged; Aged, 80 and over; Androstenes; Bone Neoplasms; Disease Progression; Disease-Free Survival; Docetaxel; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Middle Aged; Neoplasm Metastasis; Proportional Hazards Models; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Treatment Outcome | 2019 |
5 other study(ies) available for radium and Adverse Drug Event
Article | Year |
---|---|
Adverse Events Associated With Radium-223 in Metastatic Prostate Cancer: Disproportionality Analysis of FDA Data Reflecting Worldwide Utilization.
Topics: Aged; Aged, 80 and over; Drug-Related Side Effects and Adverse Reactions; Follow-Up Studies; Global Health; Humans; Male; Middle Aged; Neoplasm Metastasis; Pharmacovigilance; Prognosis; Prostatic Neoplasms; Radium; Risk Assessment; Survival Rate; United States; United States Food and Drug Administration | 2020 |
Initial Experience With Radium-223 Chloride Treatment at the Kanazawa University Hospital.
Topics: Aged; Alkaline Phosphatase; Bone and Bones; Bone Neoplasms; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Prostate-Specific Antigen; Prostatic Neoplasms, Castration-Resistant; Radium; Treatment Outcome | 2019 |
The primary care physician's role in the monitoring and management of the potential sequelae of the medical treatment of prostate cancer: early and late.
Topics: Abiraterone Acetate; Androgen Antagonists; Antineoplastic Agents; Benzamides; Denosumab; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Nitriles; Phenylthiohydantoin; Physicians, Primary Care; Professional Role; Prostatic Neoplasms, Castration-Resistant; Radioisotopes; Radium; Time Factors | 2016 |
Indonesian doctor sends her message via radio and TV.
Topics: Drug Compounding; Drug-Related Side Effects and Adverse Reactions; Humans; Indonesia; Pediatrics; Physicians; Radio; Television | 2009 |
Radio campaign to promote quality use of medicines among Italian, Mandarin and Cantonese speaking seniors in Australia.
Topics: Aged; Aged, 80 and over; Australia; China; Communication Barriers; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Emigrants and Immigrants; Female; Health Promotion; Health Status Disparities; Humans; Italy; Male; Middle Aged; Radio | 2011 |